New Delhi: IAVI, a non-profit scientific research organisation and Serum Institute of India announced an agreement with Merck to develop SARS-CoV-2 neutralising monoclonal antibodies (mAbs) co-invented by IAVI and Scripps Research as innovative interventions to address the Covid-19 pandemic. The agreement builds on the advanced antibody discovery and optimization expertise of IAVI and Scripps Research, […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.